Diversified Trust’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,879
Closed -$85.4K 904
2023
Q4
$85.4K Sell
20,879
-9,141
-30% -$25.6K ﹤0.01% 839
2023
Q3
$95.5K Buy
+30,020
New +$95.4K ﹤0.01% 787

Other funds holding ORGO

Diversified Trust's ORGO Position: Q1 2024 in Review

Diversified Trust sold out of Organogenesis Holdings (ORGO) in Q1 2024, closing a stake of 20,879 shares — an estimated $85.4K sold.

Diversified Trust first reported a position in ORGO in Q3 2023 and held it in 2 quarters. The position peaked at $95.5K in Q3 2023. 124 funds tracked by Wall St. Rank hold ORGO as of Q1 2024.

  • Diversified Trust reported no remaining Organogenesis Holdings position as of Q1 2024 after selling out during the quarter.
  • Diversified Trust sold 20,879 Organogenesis Holdings shares in Q1 2024, an estimated $85.4K.
  • Diversified Trust first reported a position in Organogenesis Holdings in Q3 2023 and held it in 2 quarters.
  • Diversified Trust's Organogenesis Holdings position peaked at $95.5K in Q3 2023.
  • 124 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2024.

Based on Diversified Trust's 13F filing for Q1 2024, filed 18 Apr 2024.